These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 3606333)

  • 1. Hat size in schizophrenia.
    Arch Gen Psychiatry; 1987 Jul; 44(7):672-6. PubMed ID: 3606333
    [No Abstract]   [Full Text] [Related]  

  • 2. A pilot study of facial, cranial and brain MRI morphometry in men with schizophrenia: part 2.
    Henriksson KM; Wickstrom K; Maltesson N; Ericsson A; Karlsson J; Lindgren F; Astrom K; McNeil TF; Agartz I
    Psychiatry Res; 2006 Oct; 147(2-3):187-95. PubMed ID: 16949799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A morphometric magnetic resonance method for measuring cranial, facial and brain characteristics for application to schizophrenia: part 1.
    Henriksson KM; Kelly BD; Lane A; Hult R; McNeil TF; Agartz I
    Psychiatry Res; 2006 Oct; 147(2-3):173-86. PubMed ID: 16952447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Schizophrenia in clinical imaging; anomalies in brain anatomy and metabolism].
    Hulshoff Pol HE; Baaré WF; Mali WP; van Ree JM; Kahn RS
    Ned Tijdschr Geneeskd; 1995 Mar; 139(10):494-7. PubMed ID: 7891755
    [No Abstract]   [Full Text] [Related]  

  • 5. Brain atrophy or dystrophy in schizophrenia: when did it happen?
    Stevens JR
    Arch Gen Psychiatry; 1994 Nov; 51(11):927. PubMed ID: 7944882
    [No Abstract]   [Full Text] [Related]  

  • 6. Structural brain imaging in schizophrenia.
    Pfefferbaum A; Marsh L
    Clin Neurosci; 1995; 3(2):105-11. PubMed ID: 7583616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [First and second generation antipsychotics and morphological and neurochemical brain changes in schizophrenia. Review of magnetic resonance imaging and proton spectroscopy findings].
    Szulc A
    Psychiatr Pol; 2007; 41(3):329-38. PubMed ID: 17900049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain and CSF volume differences in schizophrenic subtypes.
    Mitchell AJ
    Am J Psychiatry; 1995 May; 152(5):817-8. PubMed ID: 7726338
    [No Abstract]   [Full Text] [Related]  

  • 9. Brain cell membrane motion-restricted phospholipids: a cerebral 31-phosphorus magnetic resonance spectroscopy study of patients with schizophrenia.
    Puri BK; Counsell SJ; Hamilton G
    Prostaglandins Leukot Essent Fatty Acids; 2008 Dec; 79(6):233-5. PubMed ID: 18842398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain and CSF volume differences in schizophrenic subtypes.
    Nasrallah HA
    Am J Psychiatry; 1995 May; 152(5):817; author reply 818. PubMed ID: 7726337
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diagnostic brain imaging for premorbid schizophrenia].
    Kawasaki Y; Suzuki M; Takahashi T; Nakamura K; Nishiyama S; Kurachi M; Kazukawa S
    Seishin Shinkeigaku Zasshi; 2009; 111(3):282-7. PubMed ID: 19499637
    [No Abstract]   [Full Text] [Related]  

  • 12. Cerebral morphometry and clozapine treatment in schizophrenia.
    Bilder RM; Wu H; Chakos MH; Bogerts B; Pollack S; Aronowitz J; Ashtari M; Degreef G; Kane JM; Lieberman JA
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():53-6. PubMed ID: 7961574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinguishing vulnerability, prediction, and progression in the preschizophrenic brain.
    Lawrie S
    Arch Gen Psychiatry; 2007 Feb; 64(2):250-1; author reply 252-3. PubMed ID: 17283293
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative study of proton and phosphorus magnetic resonance spectroscopy in schizophrenia at 4 Tesla.
    Théberge J; Al-Semaan Y; Jensen JE; Williamson PC; Neufeld RW; Menon RS; Schaefer B; Densmore M; Drost DJ
    Psychiatry Res; 2004 Nov; 132(1):33-9. PubMed ID: 15546701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Morphological study on brains of patients with schizophrenia--its application to the objective diagnosis].
    Suzuki M; Kawasaki Y; Zhou S; Takahashi T; Kuratomo M
    Seishin Shinkeigaku Zasshi; 2006; 108(6):654-60. PubMed ID: 16910546
    [No Abstract]   [Full Text] [Related]  

  • 16. Whole-brain morphometric study of schizophrenia revealing a spatially complex set of focal abnormalities.
    Davatzikos C; Shen D; Gur RC; Wu X; Liu D; Fan Y; Hughett P; Turetsky BI; Gur RE
    Arch Gen Psychiatry; 2005 Nov; 62(11):1218-27. PubMed ID: 16275809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain cell membrane motion-restricted phospholipids in patients with schizophrenia who have seriously and dangerously violently offended.
    Puri BK; Counsell SJ; Hamilton G; Bustos MG; Treasaden IH
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):751-4. PubMed ID: 18164794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advances in neuroimaging in schizophrenia: magnetic resonance spectroscopy].
    Galińska B; Szulc A; Walecki J; Kubas B; Tarasów E
    Pol Merkur Lekarski; 2003 Sep; 15(87):278-80. PubMed ID: 14679857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.
    Velakoulis D; Wood SJ; Wong MT; McGorry PD; Yung A; Phillips L; Smith D; Brewer W; Proffitt T; Desmond P; Pantelis C
    Arch Gen Psychiatry; 2006 Feb; 63(2):139-49. PubMed ID: 16461856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of nuclear magnetic resonance imaging in psychiatric research.
    Potts NL; Davidson JR; Krishnan KR
    J Clin Psychiatry; 1993 Dec; 54 Suppl():13-8. PubMed ID: 8276745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.